Uncategorized

The Gamble Behind a Takeover of Kenvue, Maker of Tylenol

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.

Related posts
Uncategorized

Companies Rush to Close Daring Deals Under Trump

Companies are seizing on what many say is perhaps the most favorable regulatory environment for…
Read more
Uncategorized

Adam O’Neal Resigns as Washington Post Opinion Editor

Adam O’Neal inherited a mandate from the paper’s owner, Jeff Bezos, to shift toward “personal…
Read more
Uncategorized

Warsh Considers Reducing Frequency of Fed Policy Meetings

The Federal Reserve has met at least eight times a year for decades. Reducing the number of meetings…
Read more
Newsletter
Become a Trendsetter
Sign up for Davenport’s Daily Digest and get the best of Davenport, tailored for you.

Leave a Reply

Your email address will not be published. Required fields are marked *